Publications by authors named "Vigleik Jessen"

4 Publications

  • Page 1 of 1

1-year follow-up of 920 hip and knee arthroplasty patients after implementing fast-track.

Acta Orthop 2015 Feb 1;86(1):78-85. Epub 2014 Sep 1.

Orthopedic Research Center, Orthopaedic Department , Trondheim University Hospital.

Background: Fast-track has become a well-known concept resulting in improved patient satisfaction and postoperative results. Concerns have been raised about whether increased efficiency could compromise safety, and whether early hospital discharge might result in an increased number of complications. We present 1-year follow-up results after implementing fast-track in a Norwegian university hospital.

Methods: This was a register-based study of 1,069 consecutive fast-track hip and knee arthroplasty patients who were operated on between September 2010 and December 2012. Patients were followed up until 1 year after surgery.

Results: 987 primary and 82 revision hip or knee arthroplasty patients were included. 869 primary and 51 revision hip or knee patients attended 1-year follow-up. Mean patient satisfaction was 9.3 out of a maximum of 10. Mean length of stay was 3.1 days for primary patients. It was 4.2 days in the revision hip patients and 3.9 in the revision knee patients. Revision rates until 1-year follow-up were 2.9% and 3.3% for primary hip and knee patients, and 3.7% and 7.1% for revision hip and knee patients. Function scores and patient-reported outcome scores were improved in all groups.

Interpretation: We found reduced length of stay, a high level of patient satisfaction, and low revision rates, together with improved health-related quality of life and functionality, when we introduced fast-track into an orthopedic department in a Norwegian university hospital.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
February 2015

Internal quality register for joint prostheses.

Tidsskr Nor Laegeforen 2012 Mar;132(6):626-7

Orthopaedic Research Centre, St. Olavs Hospital and Department of Neuroscience, Norwegian University of Science and Technology, Norway.

View Article and Find Full Text PDF

Download full-text PDF

Source Listing
March 2012

Comparison of in vitro and in vivo complement activation by metal and bioabsorbable screws used in anterior cruciate ligament reconstruction.

Arthroscopy 2006 May;22(5):489-96

Department of Orthopaedics, Trondheim University Hospital, Institute of Immunology, Trondheim, Norway.

Purpose: The purpose of the study was to evaluate the biocompatibility of polylactide (PLLA) screws in comparison with standard metal screws for fixation of the patellar tendon graft in human anterior cruciate ligament (ACL) reconstruction.

Methods: A total of 41 patients (22 women and 19 men) were prospectively randomized for the use of metal interference screws (20 patients) or biologically resorbable PLLA screws from Linvatec, Largo, FL (21 patients). Average age at the time of surgery was 26 years (15 to 51 y). Synovial fluid and plasma were collected preoperatively and after 6 weeks in both groups. Plasma was analyzed for C5a and synovial fluid, as well as for terminal SC5b-9 complement complex (TCC) and interleukin (IL)-8. At 1 year after surgery, serum was incubated with metal, PLLA, and no screws; this was followed by analysis of C5a after 1 and 6 hours of incubation. Inflammatory mediators were measured through enzyme-linked immunosorbent assay (ELISA).

Results: In the BioScrew group, 4 patient samples showed high C5a concentration in synovial fluid after 6 weeks, but no statistically significant difference was observed between the 2 groups (P = .11). One patient in the BioScrew group had a high TCC value after 6 weeks, but no statistically significant difference was seen between the 2 groups (P = .20). In the in vitro study, no increased C5a generation was observed in sera incubated with a BioScrew or a metal screw compared with controls.

Conclusions: No statistically significant difference was observed between the BioScrew and metal screw groups concerning C5a, TCC, and IL-8 formation. However, some patients in the BioScrew group showed elevated values.

Level Of Evidence: Level II, prospective randomized trial.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
May 2006